Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Argus Health
Moodys
QuintilesIMS
Chinese Patent Office
McKesson
Mallinckrodt
Deloitte
US Army

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 3,681,500

« Back to Dashboard

Summary for Patent: 3,681,500
Title: SPRAY COMPOSITIONS FOR TREATMENT OF OBSTRUCTIVE DISORDERS OF THE RESPIRATORY TRACT AND METHODS THEREFOR
Abstract:Inhalation spray compositions for the treatment of obstructive disorders of the respiratory tract, comprising as an active ingredient a physiologically compatible quaternary salt of N-isopropyl-N-methyl-nortropine tropic acid ester, optionally in combination with a mucolytic and/or a bronchospasmolytic.
Inventor(s): Zeile; Karl (Ingelheim am Rhein, DT), Schulz; Werner (Ingelheim am Rhein, DT), Banholzer; Rolf (Ingelheim am Rhein, DT), Wick; Helmut (Ingelheim am Rhein, DT)
Assignee: Boehringer Ingelheim GmbH (Ingelheim am Rhine, DT)
Application Number:05/094,951
Patent Claim Types:
see list of patent claims
Use; Composition; Compound; Formulation;

Drugs Protected by US Patent 3,681,500

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 3,681,500

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
P 19 62 496.5Dec 12, 1969

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Harvard Business School
Express Scripts
Baxter
Dow
Mallinckrodt
Medtronic
Johnson and Johnson
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.